KA

Kei Roger Aoki

AB AbbVie: 123 patents #6 of 1,308Top 1%
NC Nippon Paint Holdings Co.: 34 patents #7 of 834Top 1%
SY Syntaxin: 12 patents #7 of 26Top 30%
IL Ipsen Bioinnovation Limited: 3 patents #10 of 23Top 45%
PC Polyplastics Co.: 2 patents #103 of 292Top 40%
📍 Irvine, CA: #13 of 6,241 inventorsTop 1%
🗺 California: #853 of 386,348 inventorsTop 1%
Overall (All Time): #5,272 of 4,157,543Top 1%
162
Patents All Time

Issued Patents All Time

Showing 76–100 of 162 patents

Patent #TitleCo-InventorsDate
7671177 Leucine-based motif and clostridial neurotoxins Lance E. Steward, Todd M. Herrington 2010-03-02
7659092 Fusion proteins Keith Foster, John Chaddock, Philip Marks, Patrick Stancombe, Joseph Francis +1 more 2010-02-09
7658933 Non-cytotoxic protein conjugates Keith Foster, John Chaddock, Charles Penn, Joseph Francis, Lance E. Steward 2010-02-09
7645570 Botulinum toxin screening assays Ester Fernandez-Salas, Patton E. Garay 2010-01-12
7641833 Method for producing a pellet from a fiber-filled resin composition and injection-molded products thereof Masayuki Sakai, Kazufumi Watanabe 2010-01-05
7638294 Fluorescence polarization assays for determining clostridial toxin activity Dudley J. Williams, Marcella A. Gilmore, Lance E. Steward, Marc Verhagen 2009-12-29
7635574 Fluorescence polarization assays for determining clostridial toxin activity Dudley J. Williams, Marcella A. Gilmore, Lance E. Steward, Marc Verhagen 2009-12-22
7632655 Fluorescence polarization assays for determining clostridial toxin activity Dudley J. Williams, Marcella A. Gilmore, Lance E. Steward, Marc Verhagen 2009-12-15
7628992 Modification of clostridial toxins for use as transport proteins James Oliver Dolly, Larry A. Wheeler, Michael E. Garst 2009-12-08
7598027 Botulinum toxin screening assays Ester Fernandez-Salas, Patton E. Garay 2009-10-06
7534863 Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins Lance E. Steward, Ester Fernandez-Salas, Todd M. Herrington 2009-05-19
7514088 Multivalent Clostridial toxin derivatives and methods of their use Lance E. Steward, Fernandez-Salas Ester, Joseph Francis, Shengwin Li, Marcella A. Gilmore 2009-04-07
7495069 FRET protease assays for botulinum serotype A/E toxins Lance E. Steward, Ester Fernandez-Salas 2009-02-24
7491799 Modified botulinum neurotoxins Lance E. Steward, Ester Fernandez-Salas, Todd M. Herrington 2009-02-17
7468188 Multi-step therapy for injured muscles Gregory F. Brooks 2008-12-23
7456272 Neurotoxins with enhanced target specificity Wei-Jen Lin, Lance E. Steward 2008-11-25
7399607 Fluorescence polarization assays for determining clostridial toxin activity Dudley J. Williams, Marcella A. Gilmore, Lance E. Steward, Marc Verhagen 2008-07-15
7393925 Leucine-based motif and Clostridial neurotoxins Lance E. Steward, Todd M. Herrington 2008-07-01
7381700 Methods for treating pain associated with arthritis Micheal W. Grayston, Steven R. Carlson, Judith M. Leon 2008-06-03
7374896 GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity Lance E. Steward, Marcella A. Gilmore 2008-05-20
7374769 Method for treating a trigeminal neuralgia by peripheral administration of a neurotoxin Minglei Cui, Stephen W. Jenkins 2008-05-20
7361358 Treatment of a facial pain by peripheral administration of a neurotoxin Minglei Cui, Stephen W. Jenkins 2008-04-22
7332567 Fret protease assays for clostridial toxins Lance E. Steward, Ester Fernandez-Salas 2008-02-19
7291344 Method for treating phantom pain by peripheral administration of a neurotoxin Minglei Cui, Stephen W. Jenkins 2007-11-06
7288260 Method for treating pain by peripheral administration of a neuroptoxin Minglei Cui, Stephen W. Jenkins 2007-10-30